SGLT2 Inhibitors Reduce Heart Failure Hospitalization

TUESDAY, April 12, 2022 -- For patients with heart failure, sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce hospitalization for heart failure and cardiovascular death, but increase the risk of genital infections, according to a review...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news